Abstract
Turner syndrome (TS) is associated with coronary artery disease (CAD), an important cause of premature death in TS. However, the determinants of CAD in women with TS remain unknown. In a cross-sectional study design, 168 women without clinical evidence of CAD (115 with TS and 53 without TS) were assessed for the presence and volume of subclinical CAD using coronary CT angiography. Karyotype, the presence of congenital heart defects and conventional cardiovascular risk factors were also registered. Comparative analyses were performed (1) between women with and without TS and (2) in the TS group, between women with and without subclinical CAD. The prevalence of CAD, in crude and adjusted analyses, was not increased for women with TS (crude prevalence: 40 [35%] in TS vs. 25 [47%] in controls, p = 0.12). The volume of atherosclerosis was not higher in women with TS compared with controls (median and interquartile range 0 [0–92] in TS vs. 0 [0–81]mm3 in controls, p = 0.29). Among women with TS, women with subclinical CAD were older (46 ± 13 vs. 37 ± 11 years, p < 0.001), had higher blood pressure (systolic blood pressure 129 ± 16 vs. 121 ± 16 mmHg, p < 0.05) and were more frequently diagnosed with type 2 diabetes (5 [13%] vs. 2 [3%], p < 0.05). Karyotype or congenital heart defects were not associated with subclinical CAD. Some women with TS show early signs of CAD, however overall, not more than women without TS. Conventional cardiovascular risk factors were the principal determinants of CAD also in TS, and CAD prevention strategies should be observed.
ClinicalTrial.gov Identifier: NCT01678261 (https://clinicaltrials.gov/ct2/show/NCT01678261)
Similar content being viewed by others
Abbreviations
- CAD:
-
Coronary artery disease
- CP:
-
Calcified plaque
- HbA1c:
-
Hemoglobin A1c
- LDL:
-
Low-density lipoprotein
- LDNCP:
-
Low-density non-calcified plaque
- NCP:
-
Non-calcified plaque
- TGF:
-
Transforming growth factor
- TP:
-
Total plaque
- TS:
-
Turner syndrome
References
Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA, United Kingdom Clinical Cytogenetics (2008) Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 93:4735–4742
Schoepp M, Hannah-Shmouni F, Matta J, Ghanem AM, Hanover JA, Abd-Elmoniem KZ, Gharib AM (2018) Coronary calcification in adults with Turner syndrome. Genet Med 20:664–668
Conroy RM, Pyorala K, Fitzgerald AE, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov, Thomsen, Tunstall-Pedoe, Tverdal, Wedel, Whincup, Wilhelmsen, Graham, and group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD et al (2010) Emerging risk factors diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222
Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, Sandberg DE, International Turner Syndrome Consensus (2017) Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol 177:G1–G70
Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt C (2006) Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 91:3897–3902
El-Mansoury M, Barrenas ML, Bryman I, Hanson C, Larsson C, Wilhelmsen L, Landin-Wilhelmsen K (2007) Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome. Clin Endocrinol (Oxf) 66:744–751
Viuff MH, Trolle C, Wen J, Jensen JM, Norgaard BL, Gutmark EJ, Gutmark-Little I, Mortensen KH, Gravholt CH, Andersen NH (2016) Coronary artery anomalies in Turner Syndrome. J Cardiovasc Comput Tomogr 10:480–484
Thunstrom S, Krantz E, Thunstrom E, Hanson C, Bryman I, Landin-Wilhelmsen K (2019) Incidence of aortic dissection in Turner syndrome. Circulation 139:2802–2804
Koenraadt WM, Siebelink HM, Bartelings MM, Schalij MJ, van der Vlugt MJ, van den Bosch AE, Budde RP, Roos-Hesselink JW, Duijnhouwer AL, van den Hoven AT, DeRuiter MC (2019) Coronary anatomy in Turner syndrome versus patients with isolated bicuspid aortic valves. Heart 105:701–707
Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G, Italian Study Group for Turner's Syndrome (1997) Spontaneous pubertal development in Turner's syndrome. J Clin Endocrinol Metab 82:1810–1813
Lobo RA, Pickar JH, Stevenson JC, Mack WJ, Hodis HN (2016) Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. Atherosclerosis 254:282–290
Davis SM, Geffner ME (2019) Cardiometabolic health in Turner syndrome. Am J Med Genet C Semin Med Genet 181:52–58
Hjerrild BE, Mortensen KH, Sorensen KE, Pedersen EM, Andersen NH, Lundorf E, Hansen KW, Horlyck A, Hager A, Christiansen JS, Gravholt CH (2010) Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study. J Cardiovasc Magn Reson 12:12
Mortensen KH, Hjerrild BE, Stochholm K, Andersen NH, Sorensen KE, Lundorf E, Horlyck A, Pedersen EM, Christiansen JS, Gravholt CH (2011) Dilation of the ascending aorta in Turner syndrome—a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 13:24
Funck KL, Laugesen E, Ovrehus K, Jensen JM, Norgaard BL, Dey D, Hansen TK, Poulsen PL (2017) Increased high-risk coronary plaque burden is associated with arterial stiffness in patients with type 2 diabetes without clinical signs of coronary artery disease: a computed tomography angiography study. J Hypertens 35:1235–1243
Raff GL, Abidov A, Achenbach S, Berman DS, Boxt LM, Budoff MJ, Cheng V, DeFrance T, Hellinger JC, Karlsberg RP (2009) SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr 3:122–136
Dey D, Cheng VY, Slomka PJ, Nakazato R, Ramesh A, Gurudevan S, Germano G, Berman DS (2009) Automated 3-dimensional quantification of noncalcified and calcified coronary plaque from coronary CT angiography. J Cardiovasc Comput Tomogr 3:372–382
Perez-Pomares JM, de la Pompa JL, Franco D, Henderson D, Ho SY, Houyel L, Kelly RG, Sedmera D, Sheppard M, Sperling S, Thiene G et al (2016) Congenital coronary artery anomalies: a bridge from embryology to anatomy and pathophysiology–a position statement of the development, anatomy, and pathology ESC Working Group. Cardiovasc Res 109:204–216
Belotti F (2015) twopm: Two-part models. Stata J 15:3–20
Jansen H, Samani NJ, Schunkert H (2014) Mendelian randomization studies in coronary artery disease. Eur Heart J 35:1917–1924
Freriks K, Timmers HJ, Netea-Maier RT, Beerendonk CC, Otten BJ, Traas MA, Mieloo H, van de Zande GW, Hoefsloot LH, Hermus AR, Smeets DF (2013) Buccal cell FISH and blood PCR-Y detect high rates of X chromosomal mosaicism and Y chromosomal derivatives in patients with Turner syndrome. Eur J Med Genet 56:497–501
Mortensen KH, Andersen NH, Gravholt CH (2012) Cardiovascular phenotype in Turner syndrome–integrating cardiology, genetics, and endocrinology. Endocr Rev 33:677–714
Boudoulas KD, Wolfe B, Ravi Y, Lilly S, Nagaraja HN, Sai-Sudhakar CB (2015) The aortic stenosis complex: aortic valve, atherosclerosis, aortopathy. J Cardiol 65:377–382
Viuff MH, Berglund A, Juul S, Andersen NH, Stochholm K, Gravholt CH (2020) Sex hormone replacement therapy in Turner syndrome: impact on morbidity and mortality. J Clin Endocrinol Metab 105:468–478
Cho I, Al'Aref SJ, Berger A, Ó Hartaigh B, Gransar H, Valenti V, Lin FY, Achenbach S, Berman DS, Budoff MJ, Callister TQ et al (2018) Prognostic value of coronary computed tomographic angiography findings in asymptomatic individuals: a 6-year follow-up from the prospective multicentre international CONFIRM study. Eur Heart J 39:934–941
Deseive S, Straub R, Kupke M, Broersen A, Kitslaar PH, Stocker TJ, Massberg S, Hadamitzky M, Hausleiter J (2019) Impact of diabetes on coronary artery plaque volume by coronary CT angiography and subsequent adverse cardiac events. J Cardiovasc Comput Tomogr 13:31–37
Muhlestein JB, Lappe DL, Lima JA, Rosen BD, May HT, Knight S, Bluemke BA, Towner SR, Le V, Bair TL, Vavere AL (2014) Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA 312:2234–2243
Johnson B, Buelow M, Earing M, Cohen S, Bartz P, Ginde S (2019) Coronary artery disease screening in adults with congenital heart disease prior to cardiac surgery. Congenit Heart Dis 14:895–900
Acknowledgements
Claus H. Gravholt is a member of the European Reference Network on Rare Endocrine Conditions (ENDO-ERN), Project ID number 739543.
Funding
Anthonie Duijnhouwer, Lidia Bons and Jolien Roos-Hesselink received a grant from the Netherlands Heart Foundation (Grant number NHS 2013T093). Claus H. Gravholt received grants from the Novo Nordisk Foundation (Grant agreement NNF13OC0003234 and NNF15OC0016474).
Author information
Authors and Affiliations
Contributions
KLF: formal analysis, methodology, software, visualization, roles/writing—original draft; RPJB: project administration; resources, supervision, writing—review and editing; MHV: investigation, project administration, writing—review and editing; JW: investigation, project administration, writing—review and editing; JMJ: methodology, writing—review and editing; BLN: methodology, writing—review and editing; LRB: investigation, funding acquisition, project administration, writing—review and editing; ALD: project administration; resources, supervision, writing—review and editing; DD: methodology, software, writing—review and editing; KHM: methodology, writing—review and editing; NHA: methodology, writing—review and editing; JWRH: project administration; resources, supervision, writing—review and editing; CHG: project administration; resources, supervision, writing—original draft.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Funck, K.L., Budde, R.P.J., Viuff, M.H. et al. Coronary plaque burden in Turner syndrome a coronary computed tomography angiography study. Heart Vessels 36, 14–23 (2021). https://doi.org/10.1007/s00380-020-01660-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-020-01660-7